Document is current
Any future updates will be listed below
-
Authors
Smith, Alexis R.
Nar, Rukiye
Li, Yafang
Gour, Abhishek
Sharma, Abhisheak
Qian, Zhijian
Zheng, Guangrong
Wu, Zhixing https://orcid.org/0000-0001-5624-8003
-
Funding
Funding for this research was provided by:
National Cancer Institute (T32CA257923)
Cancer Center, University of Florida Health (381.915)
- License Information
-
More Information
Article History
Received: 25 June 2025
Accepted: 27 August 2025
First Online: 5 September 2025
Compliance with ethical standards
:
: ARS, RN, YL, ZQ, GZ, and ZW are co-inventors of a patent application for the use of METTL3/14 PROTACs as antitumor agents.
